Dr Michael Jarvis

I have over 35 years’ research experience in large pharma covering all phases of drug discovery research including new target identification, validation, clinical candidate selection, and clinical development (both proof of concept studies and life-cycle management). I have discovered and developed numerous first in class molecules for interrogating purinergic cell surface receptors and numerous voltage/ligand-gated ion channels. Additionally, I have also provided scientific and medical oversight for established drug therapies in multiple therapeutic areas including epilepsy, chronic pain, dyslipidemia, hypertension, and metabolic disorders. I have authored/co-authored 260 peer-reviewed publications (h=73, i10 = 198). I am a former President of the American Society for Pharmacology and Experimental Therapeutics (ASPET). Additionally, I have previously served as Editor-in-Chief of Pharmacology Research & Perspectives (PR&P) and ASPET’s flagship journal, The Journal of Pharmacology and Experimental Therapeutics (JPET). I currently serve as Ethics Editor for the ASPET Journals.